NAACCR Item #3942: CA 19-9 PreTX Lab Value
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3,942 | 6 | NAACCR | 2021 | 21 |
NAACCR XML: Tumor.ca199PretxLabValue
Alternate Names
Carbohydrate Antigen 19-9 Pretreatment Lab Value
Description
Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer.
Rationale
CA 19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+.
Codes
| 0.0 | 0.0 Units/milliliter (U/ml) exactly |
| 0.1-9999.9 | 0.1-9999.9 U/ml Exact value to nearest tenth in U/ml) |
| XXXX.1 | 10,000 U/ml or greater |
| XXXX.2 | Lab value not available, physician states CA 19-9 is negative/normal |
| XXXX.3 | Lab value not available, physician states CA 19-9 is positive/elevated/high |
| XXXX.7 | Test ordered, results not in chart |
| XXXX.8 | Not applicable: Information not collected for this case If this information is required by your standard setter, use of code XXXX.8 may result in an edit error. |
| XXXX.9 | Not documented in medical record CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value not assessed or unknown if assessed |
| Blank | Diagnosis year is prior to 2021 |
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.